300529 健帆生物
按盤價 
16.380 -1.440 (-8.081%)
16.380 -1.440 (-8.081%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 11.023 | 15.658 | 25.309 | 12.987 | 25.661 |
| 總資產報酬率 ROA (%) | 7.204 | 9.874 | 15.013 | 7.965 | 17.397 |
| 投入資產回報率 ROIC (%) | 8.034 | 11.163 | 16.908 | 8.871 | 19.297 | 邊際利潤分析 |
| 銷售毛利率 (%) | 78.456 | 78.701 | 80.779 | 79.741 | 82.335 |
| 營業利潤率 (%) | 43.784 | 34.336 | 39.045 | 28.289 | 41.320 |
| 息稅前利潤/營業總收入 (%) | 45.123 | 34.882 | 38.823 | 25.340 | 40.097 |
| 淨利潤/營業總收入 (%) | 37.094 | 26.427 | 30.410 | 22.146 | 35.359 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 97.598 | 101.993 | 95.923 | 96.293 | 92.583 |
| 價值變動淨收益/利潤總額(%) | 5.519 | 8.103 | 4.281 | 0.000 | 1.034 |
| 營業外收支淨額/利潤總額(%) | -1.101 | -4.644 | -3.814 | -4.376 | -1.244 | 償債能力分析 |
| 流動比率 (X) | 2.109 | 5.812 | 3.630 | 3.993 | 4.592 |
| 速動比率 (X) | 1.907 | 5.231 | 3.190 | 3.529 | 4.105 |
| 資產負債率 (%) | 33.423 | 35.823 | 38.057 | 43.123 | 33.713 |
| 帶息債務/全部投入資本 (%) | 21.994 | 21.819 | 26.709 | 32.355 | 23.883 |
| 股東權益/帶息債務 (%) | 331.309 | 334.058 | 260.957 | 197.769 | 304.068 |
| 股東權益/負債合計 (%) | 199.158 | 179.174 | 162.726 | 131.670 | 195.735 |
| 利息保障倍數 (X) | 24.846 | 16.852 | 32.037 | -14.371 | -56.060 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 6.559 | 7.401 | 8.626 | 27.770 | 35.460 |
| 存貨周轉天數 (天) | 226.148 | 264.446 | 252.816 | 339.301 | 223.177 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 07/08/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
